Latest Research

Arterial stiffness is associated with aging, obesity, comorbidities, and cardiovascular disease in the general population and needs to be further studied in people with MS.

Comprehensive care addressing issues that are common in older people with MS, including polypharmacy and comorbidity, may improve quality of life, adherence, and overall health.

Possible future applications of optogenetics in MS therapy include the induction of oligodendrocyte proliferation, myelin synthesis, enhancing the repair of demyelinating processes, and modulating the severity of MS symptoms.

Qualitative findings highlight gaps in patient education, access to evidence-based interventions, and understanding of the experiences of people with multiple sclerosis and bladder and bowel dysfunction across cultures and health care systems.

Respiratory dysfunction in multiple sclerosis (MS) is associated with disease progression, respiratory muscle weakness, fatigue, impaired trunk control, and thoracic kyphosis.

This features the complete abstract book for the 40th annual Consortium of Multiple Sclerosis Centers annual meeting.

Understanding age-related changes in multiple sclerosis (MS) may help inform treatment decisions that address normal aging and MS-related aging processes.